The Safety and Immune-efficacy of Fucoidan from Gagome Kombu (Kjellmaniella crassifolia) on Women with the History of Gynecological Cancer
- VernacularTitle:The Safety and Immune-efficacy of Fucoidan from Gagome Kombu (Kjellmaniella crassifolia) on Women with the History of Gynecological Cancer
- Author:
Hoko KYO
1
;
Shintaro HASHIMOTO
2
;
Koji KOIKE
3
;
Kazuo UEBABA
4
;
Hiromu OHNOGI
1
;
Nobutaka SUZUKI
5
Author Information
- Keywords: Fucoidan; Gagome Kombu; gynecological cancer; immune-efficacy; safety
- From:Japanese Journal of Complementary and Alternative Medicine 2018;15(1):29-35
- CountryJapan
- Language:Japanese
- Abstract: Objective: Fucoidan is a sulfated polysaccharide in brown seaweeds. Previous studies show that fucoidan from Gagome kombu (GKF) exhibit immune-enhancing capabilities on healthy adults. In this study, we focused on the women with the history of gynecological cancer and evaluated the safety and immune-efficacy of GKF.Methods: Ten Japanese women subjects were chosen to ingest the test samples (1 drink / day containing 200 mg GKF) for 4 weeks. Before and after ingestion, blood chemistry analysis, hematological analysis, urinalysis and immune analysis were conducted. Result: Results showed no adverse clinical changes in blood and urinary analysis. In addition, no serious symptoms were observed. Moreover, decrease of serum levels of Eotaxin, IL-7, IL-17 and VEGF were observed.Conclusion: These results indicate that in the case of women with the history of gynecological cancer, GKF is a safe functional food ingredient.